<DOC>
	<DOCNO>NCT02487550</DOCNO>
	<brief_summary>The purpose study show vaccination autologous dendritic cell pulse tumor lysate combination Cytokine-Induced Killer Cell ( CIK ) induce measurable immune response patient renal cell carcinoma , evaluate clinical effect regimen .</brief_summary>
	<brief_title>DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell Treating</brief_title>
	<detailed_description>The purpose study show vaccination autologous dendritic cell pulse tumor lysate combination Cytokine-Induced Killer Cell ( CIK ) induce measurable immune response patient renal cell carcinoma , evaluate clinical effect regime . Primary 1 . Determine clinical response ( objective response , progression-free survival , overall survival ) patient renal cell carcinoma treat autologous dendritic cell ( DC ) load autologous tumor lysate ( DC vaccine ) combination Cytokine-Induced Killer Cell ( CIK ) . Secondary 1 . Determine cellular immune response response term immuknow assay , correlate immune response objective clinical response patient treat regimen . 2 . Determine safety multiple administration regimens patient .</detailed_description>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Histologically proven renal cell carcinoma Age : &gt; 18 WHO ECOG Performance Status 01 At least one measurable tumor lesion accord RECIST criterion . Life expectancy 3 month Written inform consent Patients history neoplastic disease le 5 year ago ( except treat carcinoma situ cervix basal/squamous cell carcinoma skin ) . Patients metastatic disease central nervous system ( CNS ) . Patients significant illness include severe allergy , asthma , angina pectoris congestive heart failure . Patients acute chronic infection include HIV . Patients pregnant nursing . Patients receive antineoplastic therapy include chemotherapy immunotherapy le 4 week begin trial . Patients receive corticosteroid immunosuppressive agent . Patients active autoimmune disease lupus erythematosus , rheumatoid arthritis thyroiditis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Renal neoplasma</keyword>
	<keyword>CIK cell</keyword>
</DOC>